🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to learn about the safety and t...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2024-12-31
Trial ID
NCT06668584
Treatments Being Tested
This phase III trial compares the effect of usual treatment of chemotherapy...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2021-01-25
Trial ID
NCT04530565
Treatments Being Tested
This phase I/II trial finds the best dose, side effects and how well giving...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-02-04
Trial ID
NCT04797767
This randomized phase III trial studies rituximab with bendamustine hydroch...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2014-01-15
Trial ID
NCT01886872
This phase II trial tests whether treosulfan, fludarabine, and rabbit antit...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2022-04-19
Trial ID
NCT04965597
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
The outcome of HMA-refractory patients with MDS or AML is dismal with a med...
Status
Terminated
Location
CHU Nantes
Start Date
2016-07
Trial ID
NCT02992860
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
This phase II Pediatric MATCH screening and multi-sub-trial studies how wel...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-07-31
Trial ID
NCT03155620
Treatments Being Tested
This phase II trial studies the effects of the combination of olaparib and ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2018-09-27
Trial ID
NCT03660826